Page 94 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors
P. 94
92
Chapter 5
48 Pires F, da Cruz Perez D, de Almeida O, et al. Estrogen receptor expression in salivary gland mucoepidermoid carcinoma and adenoid cystic carcinoma. Pathol Oncol Res 2004; 10: 166-168
49 Shick P, Riordan G, Foss R. Estrogen and progesterone receptors in salivary gland adenoid cystic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 440-444
50 Can N, Lingen MW, Mashek H, et al. Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors. Head Neck Pathol 0 DOI:10.1007/s12105-017-0833-y.
51 Kolude B, Adisa A, Adeyemi B, et al. Immunohistochemical expression of oestrogen receptor-α and progesterone receptor in salivary gland tumours. J Oral Pathol Med 2013; 42: 716-719
52 Williams MMD, D R, Jr BG, et al. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol 2007; 31: 1645-1652
53 Younes M, N H. Estrogen receptor β. Arch Pathol Lab Med 2011; 135: 63-66
54 Keller G, Steinmann D, Quaas A, et al. New concepts of personalized therapy in salivary gland
carcinomas. Oral Oncol 2017; 68: 103-113
55 Elkin A, Jacobs C. Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases. J Cancer
Res Clin Oncol 2008; 134: 1151–1153
56 Alfieri S, Granata R, Bergamini C, et al. Systemic therapy in metastatic salivary gland carcinomas: A
pathology-driven paradigm? Oral Oncol 2017; 66: 58-63
57 Lagha A, Chraiet N, Ayadi M, et al. Systemic therapy in the management of metastatic or advanced
salivary gland cancers. Oral Oncol 2012; 48: 948-957
58 Shen TK, Teknos TN, Toland AE, et al. Salivary Gland Cancer in BRCA -Positive Families. JAMA
Otolaryngol Neck Surg 2014; 140: 1213
59 Mersch J, Jackson MA, Park M, et al. Cancers associated with BRCA1 and BRCA2 mutations other
than breast and ovarian. Cancer 2015; 121: 269-275
60 Lubiński J, Tarnowska C, Jaworowska E, et al. Pleomorphic adenoma of salivary glands does not appear
to be a BRCA-1-dependent tumour in a Polish cohort. Anticancer Res 2008; 28: 3011-3013
61 Bullerdiek J, Raabe G, Bartnitzke S, et al. Structural rearrangements of chromosome Nr 8 involving
8q12-a primary event in pleomorphic ademona of the parotid gland. Genetica 1987; 72: 85-92
62 Mark J DR. Cytogenetical observations in 100 human benign pleomorphic adenomas: specificity of the chromosomal aberrations and their relationship to sites of localized oncogenes. Anticancer Res 1986; 6: 299-308
63 Debiec-Rychter M, Valckenborgh I Van, Van Den Broeck C, et al. Histologic Localization of PLAG1 (Pleomorphic Adenoma Gene 1) in Pleomorphic Adenoma of the Salivary Gland: Cytogenetic Evidence of Common Origin of Phenotypically Diverse Cells. Lab Invest 2001; 81: 1289-1297
64 Katabi N, Gomez D, Klimstra DS, et al. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases. Hum Pathol 2010; 41: 927-934
65 Katabi N, Xu B, Jungbluth AA, et al. PLAG1 immunohistochemistry is a sensitive marker for Pleomorphic Adenoma: a comparative study with PLAG1 genetic abnormalities. Histopathology 2017; Epub ahead
